Basic Information
| LncRNA/CircRNA Name | HANR |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | Microarray, qPCR, Western blot etc. |
| Sample | hepatocellular carcinoma tissues, cell lines (Hep3B, Huh-7) |
| Expression Pattern | up-regulated |
| Function Description | HANR was demonstrated to be up-regulated in HCC patients and HCC cell lines. Increased HANR expression in HCC predicted short survival of patients. |
| Pubmed ID | 29055955 |
| Year | 2017 |
| Title | LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma |
External Links
| Links for HANR | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |